Genotype-phenotype correlation among Malaysian patients with osteogenesis imperfecta

Nadiah Mohd Nawawi, Nalini M. Selveindran, Rahmah Rasat, Chow Yock Ping, Zarina Abdul Latiff, Syed Zulkifli Syed Zakaria, A. Rahman A. Jamal, Nor Azian Abdul Murad, Bilkis Banu Abd Aziz

Research output: Contribution to journalArticle

Abstract

Background: Osteogenesis imperfecta (OI) is a rare genetic bone disease characterized by bone fragility and low bone mass. OI was mainly caused by genetic mutations in collagen genes, COL1A1 and COL1A2. Nevertheless, new genes have been identified to be causally linked to OI. The clinical features between each OI groups share great similarities and it is sometimes difficult for clinicians to diagnose the disease accurately. Here, we identify the genetic mutations of OI patients from Malaysia and correlate the genetic mutations with the clinical features. Method: Targeted sequencing of fourteen genes panel was performed to identify the mutations in 29 OI patients with type I, III, IV and V disease. The mutations were determined using Ion Torrent Suite software version 5 and variant annotation was conducted using ANNOVAR. The identified mutations were confirmed using Sanger sequencing and in silico analysis was performed to evaluate the effects of the candidate mutations at protein level. Results: Majority of patients had mutations in collagen genes, 48% (n = 14) in COL1A1 and 14% (n = 4) in COL1A2. Type I OI was caused by quantitative mutations in COL1A1 whereas most of type III and IV were due to qualitative mutations in both of the collagen genes. Those with quantitative mutations had milder clinical severity compared to qualitative mutations in terms of dentinogenesis imperfecta (DI), bone deformity and the ability to walk with aid. Furthermore, a few patients (28%, n = 8) had mutations in IFITM5, BMP1, P3H1 and SERPINF1. Conclusion: Majority of our OI patients have mutations in collagen genes, similar to other OI populations worldwide. Genotype-phenotype analysis revealed that qualitative mutations had more severe clinical characteristics compared to quantitative mutations. It is crucial to identify the causative mutations and the clinical severity of OI patients may be predicted based on the types of mutations.

Original languageEnglish
Pages (from-to)141-147
Number of pages7
JournalClinica Chimica Acta
Volume484
DOIs
Publication statusPublished - 1 Sep 2018

Fingerprint

Osteogenesis Imperfecta
Genetic Association Studies
Genes
Mutation
Bone
Collagen
Ions
Bone and Bones
Dentinogenesis Imperfecta
Inborn Genetic Diseases
Proteins

Keywords

  • Brittle bone disease
  • Genotype
  • Osteogenesis imperfecta
  • Phenotype

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Genotype-phenotype correlation among Malaysian patients with osteogenesis imperfecta. / Mohd Nawawi, Nadiah; Selveindran, Nalini M.; Rasat, Rahmah; Yock Ping, Chow; Abdul Latiff, Zarina; Syed Zakaria, Syed Zulkifli; A. Jamal, A. Rahman; Abdul Murad, Nor Azian; Abd Aziz, Bilkis Banu.

In: Clinica Chimica Acta, Vol. 484, 01.09.2018, p. 141-147.

Research output: Contribution to journalArticle

@article{06e1a015c0b74e51a5a8e739f831f558,
title = "Genotype-phenotype correlation among Malaysian patients with osteogenesis imperfecta",
abstract = "Background: Osteogenesis imperfecta (OI) is a rare genetic bone disease characterized by bone fragility and low bone mass. OI was mainly caused by genetic mutations in collagen genes, COL1A1 and COL1A2. Nevertheless, new genes have been identified to be causally linked to OI. The clinical features between each OI groups share great similarities and it is sometimes difficult for clinicians to diagnose the disease accurately. Here, we identify the genetic mutations of OI patients from Malaysia and correlate the genetic mutations with the clinical features. Method: Targeted sequencing of fourteen genes panel was performed to identify the mutations in 29 OI patients with type I, III, IV and V disease. The mutations were determined using Ion Torrent Suite software version 5 and variant annotation was conducted using ANNOVAR. The identified mutations were confirmed using Sanger sequencing and in silico analysis was performed to evaluate the effects of the candidate mutations at protein level. Results: Majority of patients had mutations in collagen genes, 48{\%} (n = 14) in COL1A1 and 14{\%} (n = 4) in COL1A2. Type I OI was caused by quantitative mutations in COL1A1 whereas most of type III and IV were due to qualitative mutations in both of the collagen genes. Those with quantitative mutations had milder clinical severity compared to qualitative mutations in terms of dentinogenesis imperfecta (DI), bone deformity and the ability to walk with aid. Furthermore, a few patients (28{\%}, n = 8) had mutations in IFITM5, BMP1, P3H1 and SERPINF1. Conclusion: Majority of our OI patients have mutations in collagen genes, similar to other OI populations worldwide. Genotype-phenotype analysis revealed that qualitative mutations had more severe clinical characteristics compared to quantitative mutations. It is crucial to identify the causative mutations and the clinical severity of OI patients may be predicted based on the types of mutations.",
keywords = "Brittle bone disease, Genotype, Osteogenesis imperfecta, Phenotype",
author = "{Mohd Nawawi}, Nadiah and Selveindran, {Nalini M.} and Rahmah Rasat and {Yock Ping}, Chow and {Abdul Latiff}, Zarina and {Syed Zakaria}, {Syed Zulkifli} and {A. Jamal}, {A. Rahman} and {Abdul Murad}, {Nor Azian} and {Abd Aziz}, {Bilkis Banu}",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/j.cca.2018.05.048",
language = "English",
volume = "484",
pages = "141--147",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - Genotype-phenotype correlation among Malaysian patients with osteogenesis imperfecta

AU - Mohd Nawawi, Nadiah

AU - Selveindran, Nalini M.

AU - Rasat, Rahmah

AU - Yock Ping, Chow

AU - Abdul Latiff, Zarina

AU - Syed Zakaria, Syed Zulkifli

AU - A. Jamal, A. Rahman

AU - Abdul Murad, Nor Azian

AU - Abd Aziz, Bilkis Banu

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Background: Osteogenesis imperfecta (OI) is a rare genetic bone disease characterized by bone fragility and low bone mass. OI was mainly caused by genetic mutations in collagen genes, COL1A1 and COL1A2. Nevertheless, new genes have been identified to be causally linked to OI. The clinical features between each OI groups share great similarities and it is sometimes difficult for clinicians to diagnose the disease accurately. Here, we identify the genetic mutations of OI patients from Malaysia and correlate the genetic mutations with the clinical features. Method: Targeted sequencing of fourteen genes panel was performed to identify the mutations in 29 OI patients with type I, III, IV and V disease. The mutations were determined using Ion Torrent Suite software version 5 and variant annotation was conducted using ANNOVAR. The identified mutations were confirmed using Sanger sequencing and in silico analysis was performed to evaluate the effects of the candidate mutations at protein level. Results: Majority of patients had mutations in collagen genes, 48% (n = 14) in COL1A1 and 14% (n = 4) in COL1A2. Type I OI was caused by quantitative mutations in COL1A1 whereas most of type III and IV were due to qualitative mutations in both of the collagen genes. Those with quantitative mutations had milder clinical severity compared to qualitative mutations in terms of dentinogenesis imperfecta (DI), bone deformity and the ability to walk with aid. Furthermore, a few patients (28%, n = 8) had mutations in IFITM5, BMP1, P3H1 and SERPINF1. Conclusion: Majority of our OI patients have mutations in collagen genes, similar to other OI populations worldwide. Genotype-phenotype analysis revealed that qualitative mutations had more severe clinical characteristics compared to quantitative mutations. It is crucial to identify the causative mutations and the clinical severity of OI patients may be predicted based on the types of mutations.

AB - Background: Osteogenesis imperfecta (OI) is a rare genetic bone disease characterized by bone fragility and low bone mass. OI was mainly caused by genetic mutations in collagen genes, COL1A1 and COL1A2. Nevertheless, new genes have been identified to be causally linked to OI. The clinical features between each OI groups share great similarities and it is sometimes difficult for clinicians to diagnose the disease accurately. Here, we identify the genetic mutations of OI patients from Malaysia and correlate the genetic mutations with the clinical features. Method: Targeted sequencing of fourteen genes panel was performed to identify the mutations in 29 OI patients with type I, III, IV and V disease. The mutations were determined using Ion Torrent Suite software version 5 and variant annotation was conducted using ANNOVAR. The identified mutations were confirmed using Sanger sequencing and in silico analysis was performed to evaluate the effects of the candidate mutations at protein level. Results: Majority of patients had mutations in collagen genes, 48% (n = 14) in COL1A1 and 14% (n = 4) in COL1A2. Type I OI was caused by quantitative mutations in COL1A1 whereas most of type III and IV were due to qualitative mutations in both of the collagen genes. Those with quantitative mutations had milder clinical severity compared to qualitative mutations in terms of dentinogenesis imperfecta (DI), bone deformity and the ability to walk with aid. Furthermore, a few patients (28%, n = 8) had mutations in IFITM5, BMP1, P3H1 and SERPINF1. Conclusion: Majority of our OI patients have mutations in collagen genes, similar to other OI populations worldwide. Genotype-phenotype analysis revealed that qualitative mutations had more severe clinical characteristics compared to quantitative mutations. It is crucial to identify the causative mutations and the clinical severity of OI patients may be predicted based on the types of mutations.

KW - Brittle bone disease

KW - Genotype

KW - Osteogenesis imperfecta

KW - Phenotype

UR - http://www.scopus.com/inward/record.url?scp=85048493613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048493613&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2018.05.048

DO - 10.1016/j.cca.2018.05.048

M3 - Article

VL - 484

SP - 141

EP - 147

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -